Historical record - last NADAC publication: 5/17/2023
Product Information
TELMISARTAN 40 MG TABLET is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.2721 per EA under NDC 59746044032. Its NADAC has been published 281 times since Jan 10, 2018.
The High Outlier badge above means this manufacturer's average price in the Telmisartan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/1
Manufacturer
Jubilant Cadista Pharmaceuticals Inc.NDC
59746044032
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
5/17/2023
Active Ingredients
TELMISARTANApproval Type
Generic (ANDA)
FDA Application
ANDA204164On Market Since
8/22/2016
Pharmacological Classes
Price Statistics
The NADAC for TELMISARTAN 40 MG TABLET has been published 281 times since Jan 10, 2018, and over the history we have for it it has declined 33.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2721 per EA |
|---|---|
| All-time high | $0.6750 (Sep 11, 2019) |
| All-time low | $0.2173 (Jan 18, 2023) |
| Median price | $0.3987 |
| Average price | $0.4058 |
| Largest weekly change | -27.2% (Jun 23, 2021) |
| Weeks tracked | 281 |
| Tracking since | Jan 10, 2018 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 41% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TELMISARTAN 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN 40 MG TABLET, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.2721 per EA (NDC 59746044032), effective May 24, 2023.
How has the price of TELMISARTAN 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for TELMISARTAN 40 MG TABLET has declined 33.7%. It has been tracked across 281 weekly CMS publications since Jan 10, 2018.
What are the highest and lowest recorded NADAC prices for TELMISARTAN 40 MG TABLET?
Since Jan 10, 2018, the NADAC for TELMISARTAN 40 MG TABLET has ranged from a low of $0.2173 (Jan 18, 2023) to a high of $0.6750 (Sep 11, 2019), with a median of $0.3987 per EA.
Are there cheaper alternatives to TELMISARTAN 40 MG TABLET?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TELMISARTAN 40 MG TABLET, is $0.1600 per EA — about 41% below TELMISARTAN 40 MG TABLET.
Who manufactures TELMISARTAN 40 MG TABLET?
TELMISARTAN 40 MG TABLET (NDC 59746044032) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification